PPARG and hepatocellular carcinoma: However, contrary to the CAFs-dependent pro-tumor properties, PPARγ reduces hepatoma cell metastasis by inhibiting the transcriptional activity of MMPs and smad family member 3 (SMAD3), thereby reducing hepatoma cell metastasis (Reka et al., 2010; Shen et al., 2012).